Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Gilead Sciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
GILD
Nasdaq
2836
www.gilead.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Gilead Sciences, Inc.
Gilead Delivers Lackluster Q1 Revenue on Trodelvy Miss, Oppenheimer Says
- Apr 25th, 2025 3:28 pm
GILD Down on Q1 Earnings and Sales Miss, Oncology Sales Decline
- Apr 25th, 2025 2:41 pm
Gilead Sciences Stock Falls as Slumping COVID-19, Cancer Drug Sales Hit Revenue
- Apr 25th, 2025 2:30 pm
Gilead Sciences Earnings Were Solid. Why the Stock Is Dropping.
- Apr 25th, 2025 2:03 pm
Q1 2025 Gilead Sciences Inc Earnings Call
- Apr 25th, 2025 1:40 pm
3 High Growth Tech Stocks Leading The US Market
- Apr 25th, 2025 11:38 am
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
- Apr 24th, 2025 11:00 pm
Gilead Sciences posts mixed Q1 results
- Apr 24th, 2025 9:22 pm
Gilead Sciences (GILD) Q1 Earnings and Revenues Lag Estimates
- Apr 24th, 2025 9:15 pm
Gilead Sciences (NASDAQ:GILD) Misses Q1 Revenue Estimates
- Apr 24th, 2025 8:33 pm
Gilead Dives As Its Biggest Moneymaker Misses. Here's Why It Could Still Be A 'Safe Haven' Stock.
- Apr 24th, 2025 8:16 pm
Gilead: Q1 Earnings Snapshot
- Apr 24th, 2025 8:13 pm
Gilead posts profit, says HIV prevention drug on track for mid-June
- Apr 24th, 2025 8:09 pm
Gilead Sciences Announces First Quarter 2025 Financial Results
- Apr 24th, 2025 8:02 pm
The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi
- Apr 23rd, 2025 1:25 pm
Gilead Sciences (GILD) To Report Earnings Tomorrow: Here Is What To Expect
- Apr 23rd, 2025 12:04 pm
Gilead reports topline data from Phase III trial of Trodelvy combo therapy
- Apr 22nd, 2025 2:28 pm
Is Gilead Sciences (GILD) a Cheap NASDAQ Stock to Buy According to Hedge Funds?
- Apr 22nd, 2025 1:52 pm
Cantor initiates coverage of U.S. large-cap pharma stocks: Gilead, AbbVie at Buy
- Apr 22nd, 2025 1:48 pm
Will These 5 Large Drug Maker Stocks Surpass Q1 Earnings Forecast?
- Apr 22nd, 2025 1:06 pm
Scroll